According to Stryker Corporation's latest financial reports the company has a price-to-book ratio of 6.70.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 6.12 | 9.9% |
2022-12-31 | 5.57 | -17.88% |
2021-12-31 | 6.78 | -3.65% |
2020-12-31 | 7.04 | 14.64% |
2019-12-31 | 6.14 | 22.7% |
2018-12-31 | 5.00 | -13.83% |
2017-12-31 | 5.81 | 23.6% |
2016-12-31 | 4.70 | 15.33% |
2015-12-31 | 4.07 | -1.82% |
2014-12-31 | 4.15 | 32.14% |
2013-12-31 | 3.14 | 29.56% |
2012-12-31 | 2.42 | -2.13% |
2011-12-31 | 2.48 | -15.43% |
2010-12-31 | 2.93 | -3.67% |
2009-12-31 | 3.04 | 1.87% |
2008-12-31 | 2.98 | -47.75% |
2007-12-31 | 5.71 | 6.45% |
2006-12-31 | 5.36 | -1.68% |
2005-12-31 | 5.46 | -22.7% |
2004-12-31 | 7.06 | -10.43% |
2003-12-31 | 7.88 | -11.53% |
2002-12-31 | 8.91 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Medtronic MDT | 2.02 | -69.82% | ๐ฎ๐ช Ireland |
Baxter BAX | 2.38 | -64.41% | ๐บ๐ธ USA |
Boston Scientific BSX | 5.07 | -24.27% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 7.74 | 15.57% | ๐บ๐ธ USA |
Waters Corporation WAT | 15.2 | 126.40% | ๐บ๐ธ USA |
Integra LifeSciences IART | 1.57 | -76.63% | ๐บ๐ธ USA |
Smith & Nephew
SNN | 2.01 | -69.94% | ๐ฌ๐ง UK |
Owens & Minor
OMI | 1.99 | -70.24% | ๐บ๐ธ USA |